Skip to content
2000
Volume 20, Issue 5
  • ISSN: 1570-1794
  • E-ISSN: 1875-6271

Abstract

Background: 1,2,3-Triazole-tetrazoles have received substantial attention because of their unique bioisosteric properties and an extraordinarily broad spectrum of biological activity, making them interesting for the drug design, and synthesis of a delightful class of widely investigated heterocyclic compounds. To address major health concerns, it is consequently important to devote ongoing effort to the identification and development of New Chemical Entities (NCEs) as possible anticancer medicines. Methods: We began our initial investigation of the reaction between 5-(azidomethyl)-1H-pyrrolo[ 2,3-b]pyridine and 1-phenyl substituted-5-(prop-2-yn-1-ylthio)-1 H-tetrazole under click chemistry to give the corresponding triazole precursors and screened for their cytotoxicity reported by variations in therapeutic actions of the parent molecule. All of the prepared scaffolds were characterized by proton, carbon resonance spectroscopy, IR, and mass spectral techniques. Results:When tested for in vitro antitumor activity the prepared compounds 7e, 7h had a significant anticancer activity against human adenocarcinoma Hs766T cell line with IC = 5.33, 4.92 μg/mL and Hs460 cell line with IC = 4.82, 6.15 μg/mL respectively. Final scaffolds 7f, 7h, and 7j acquire the highest potential drug binding scores ΔG = -10.42, -8.80, -9.37 Kcal/, with amino acids residues Ala A:11 (2.195 A° ), Asp A:119 (1.991 A° ), Thr A:58 (1.890 A°), Lys A:16 (1.253 A°), Asp A:38 (2.013 A°), Lys A:117 (2.046 A°) respectively and process Lipinski’s rule of five as good agents for oral bioavailability. Conclusion: The molecular framework for the synthesis of novel Aza indole 1,2,3-triazole scaffolds coupled to tetrazole core was discovered in our study and evaluated for their anticancer activity.

Loading

Article metrics loading...

/content/journals/cos/10.2174/1570179419666220822125724
2023-08-01
2024-12-10
Loading full text...

Full text loading...

/content/journals/cos/10.2174/1570179419666220822125724
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test